Literature DB >> 26628945

Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis.

Yiyun Zhang1, Bo Feng1.   

Abstract

Primary aldosteronism (PA) represents major cause of secondary hypertension, strongly associated with high cardiovascular morbidity and mortality. Aldosterone excess may influence mineral homeostasis, through higher urinary calcium (Ca) excretion reducing calcium plasma levels and leading to secondary increase of parathyrine (PTH). The purpose of the present study is to clarify the association of serum PTH and Ca levels with PA using a metaanalysis approach. We searched articles indexed in the PubMed, OVID and Sciencedirect published as of September 2014 that met our predefined criteria. Six articles with 748 subjects from 8 case-control studies were identified. Overall, pooled analysis indicated that subjects with PA had higher serum PTH concentrations and lower Ca levels than controls with essential hypertension (EH) (PTH: SMD = 1.146, 95% CI = [0.774, 1.518]; Ca: SMD = -0.698, 95% CI = [-1.102,-0.294]). Further subgroup analysis stratified by geological location found a similar pattern both in Italy and Austria (Italy: for PTH, SMD = 1.176, 95% CI = [0.758, 1.593], for Ca, SMD = -0.669, 95% CI = [-1.119,-0.219]; Austria: for PTH, SMD = 1.004, 95% CI = [0.359, 1.648], for Ca, SMD = -0.900, 95% CI = [-1.543,-0.257]). In addition, the subgroup analysis stratified by type of Ca measurement also found a similar pattern by spectrophotometry (SMD = -1.078, 95% CI = [-1.532, -0.623]), but not by ion selective electrode (SMD = -0.248, 95% CI = [-0.810, 0.315]). Sensitivity analysis showed that excluding any one study from the pooled analysis did not vary the results substantially. No evidence of publication bias was observed. In conclusion, this meta-analysis supports a significant association of PTH and Ca concentration with PA. Therefore, the high levels of PTH and low Ca concentrations in serum can be used as a variable predictor for PA.

Entities:  

Keywords:  Parathyrine; calcium; meta-analysis; primary aldosteronism

Year:  2015        PMID: 26628945      PMCID: PMC4658834     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

2.  Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell.

Authors:  C M Isales; P Q Barrett; M Brines; W Bollag; H Rasmussen
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

3.  Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.

Authors:  Stefan Pilz; Katharina Kienreich; Christiane Drechsler; Eberhard Ritz; Astrid Fahrleitner-Pammer; Martin Gaksch; Andreas Meinitzer; Winfried März; Thomas R Pieber; Andreas Tomaschitz
Journal:  J Clin Endocrinol Metab       Date:  2011-10-19       Impact factor: 5.958

4.  Effect of chronic mineralocorticoid administration on calcium excretion in the rat.

Authors:  W N Suki; R S Schwettmann; F C Rector; D W Seldin
Journal:  Am J Physiol       Date:  1968-07

Review 5.  Hormonal regulation of inner medullary collecting duct sodium transport.

Authors:  M L Zeidel
Journal:  Am J Physiol       Date:  1993-08

6.  Primary aldosteronism: emerging trends.

Authors:  Sandi-Jo Galati; Sarah M Hopkins; Khadeen C Cheesman; Rachel A Zhuk; Alice C Levine
Journal:  Trends Endocrinol Metab       Date:  2013-06-21       Impact factor: 12.015

7.  Differential expression of parathyroid hormone-related protein in adrenocortical tumors: autocrine/paracrine effects on the growth and signaling pathways in H295R cells.

Authors:  Marthe Rizk-Rabin; Guillaume Assie; Fernande Rene-Corail; Karine Perlemoine; Hinda Hamzaoui; Fréderique Tissier; Michele Lieberherr; Xavier Bertagna; Jerome Bertherat; Zhor Bouizar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

8.  Bone health and aldosterone excess.

Authors:  L Ceccoli; V Ronconi; L Giovannini; M Marcheggiani; F Turchi; M Boscaro; G Giacchetti
Journal:  Osteoporos Int       Date:  2013-05-22       Impact factor: 4.507

9.  Bone involvement in aldosteronism.

Authors:  Antonio Stefano Salcuni; Serena Palmieri; Vincenzo Carnevale; Valentina Morelli; Claudia Battista; Vito Guarnieri; Giuseppe Guglielmi; Gaetano Desina; Cristina Eller-Vainicher; Paolo Beck-Peccoz; Alfredo Scillitani; Iacopo Chiodini
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

10.  Bone and mineral metabolism in patients with primary aldosteronism.

Authors:  Luigi Petramala; Laura Zinnamosca; Amina Settevendemmie; Cristiano Marinelli; Matteo Nardi; Antonio Concistrè; Francesco Corpaci; Gianfranco Tonnarini; Giorgio De Toma; Claudio Letizia
Journal:  Int J Endocrinol       Date:  2014-04-03       Impact factor: 3.257

View more
  4 in total

1.  Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.

Authors:  Valentina Camozzi; Corrado Betterle; Anna Chiara Frigo; Veronica Zaccariotto; Martina Zaninotto; Erica De Caneva; Paola Lucato; Walter Gomiero; Silvia Garelli; Chiara Sabbadin; Monica Salvà; Miriam Dalla Costa; Marco Boscaro; Giovanni Luisetto
Journal:  Endocrine       Date:  2017-08-09       Impact factor: 3.633

2.  Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.

Authors:  Christina M Gant; Gozewijn D Laverman; Liffert Vogt; Maartje C J Slagman; Hiddo J L Heerspink; Femke Waanders; Marc H Hemmelder; Gerjan Navis
Journal:  BMC Nephrol       Date:  2017-12-20       Impact factor: 2.388

Review 3.  Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

Authors:  Juan Carlos Yugar-Toledo; Rodrigo Modolo; Ana Paula de Faria; Heitor Moreno
Journal:  Vasc Health Risk Manag       Date:  2017-10-16

4.  A Rare Aldosterone-Producing Adenoma Detected by 68Ga-pentixafor PET-CT: A Case Report and Literature Review.

Authors:  Yunying Cui; Yushi Zhang; Jie Ding; Huiping Wang; Xiaoshen Ma; Ou Wang; Xiaoyan Chang; Hao Sun; Li Huo; Anli Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.